Amplia Therapeutics (ASX:ATX) Debt-to-Asset : 0.13 (As of Sep. 2023)

Amplia Therapeutics Debt-to-Asset Chart

Amplia Therapeutics Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
Debt-to-Asset		Get a 7-Day Free Trial					-	-	0.09	0.12	0.11

Amplia Therapeutics Semi-Annual Data
	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Debt-to-Asset	Get a 7-Day Free Trial															0.09	0.11	0.12	0.13	0.11

Competitive Comparison of Amplia Therapeutics's Debt-to-Asset

For the Biotechnology subindustry, Amplia Therapeutics's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amplia Therapeutics's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Amplia Therapeutics's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Amplia Therapeutics's Debt-to-Asset falls into.

Amplia Therapeutics Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Amplia Therapeutics's Debt-to-Asset for the fiscal year that ended in Mar. 2023 is calculated as

Amplia Therapeutics's Debt-to-Asset for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amplia Therapeutics  (ASX:ATX) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Amplia Therapeutics Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Amplia Therapeutics's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Amplia Therapeutics (ASX:ATX) Business Description